The three most common bloodborne viral pathogens are hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). These are the viruses that drive workplace safety regulations, hospital protocols, and public health screening programs. But they aren’t the only ones. Several other viruses can travel through blood, and understanding the full picture helps you assess real-world risk.
The Big Three: HBV, HCV, and HIV
OSHA’s Bloodborne Pathogens Standard defines bloodborne pathogens as disease-causing microorganisms present in human blood, and it specifically names hepatitis B and HIV as examples. The CDC adds hepatitis C to round out the trio that poses the greatest occupational and public health threat. These three viruses account for the vast majority of bloodborne infections worldwide, and they differ significantly in how easily they spread, how long they survive, and how treatable they are.
Hepatitis B (HBV)
Hepatitis B is the most contagious of the three. After a single needlestick exposure to infected blood, an unvaccinated person faces a 6% to 30% chance of becoming infected. That wide range depends on how much virus is circulating in the source patient’s blood. HBV is also remarkably hardy: it can survive on environmental surfaces like countertops, medical equipment, or dried blood spots for at least seven days and still cause infection.
The incubation period for acute hepatitis B ranges from 45 to 160 days, averaging about four months. Some people clear the virus on their own, while others develop chronic infection that can lead to liver cirrhosis or liver cancer over decades. The good news is that a highly effective vaccine exists. The standard three-dose series provides over 90% protection in healthy adults, and that immunity lasts at least 30 years.
Hepatitis C (HCV)
Hepatitis C spreads through blood-to-blood contact but is far less transmissible per exposure than hepatitis B. After a needlestick involving HCV-positive blood, the infection risk is roughly 0.2%, or about two in every thousand exposures. Symptoms of acute infection typically appear within 2 to 24 weeks, with an average incubation of 6 to 7 weeks. One complicating factor is that antibody tests may not turn positive for up to three months after exposure, creating a window where infection can go undetected.
Unlike hepatitis B, there is no vaccine for hepatitis C. However, antiviral treatments developed in the last decade can cure the infection in the vast majority of cases. The bigger concern is that many people with HCV don’t know they have it. The virus often causes no symptoms for years while silently damaging the liver, which is why screening programs target people with known risk factors like past injection drug use or blood transfusions received before 1992.
HIV
HIV attacks the immune system and, without treatment, progresses to AIDS. It is the least transmissible of the three major bloodborne viruses through accidental exposure. A single needlestick from an HIV-positive source carries about a 0.3% risk of transmission, or roughly three infections per thousand exposures. HIV is also fragile outside the body. Unlike hepatitis B, it does not survive long on surfaces and cannot reproduce without a human host.
Modern antiretroviral therapy has transformed HIV from a terminal diagnosis into a manageable chronic condition. Post-exposure preventive medication, when started within hours of a potential exposure, can significantly reduce the chance of infection taking hold.
How These Viruses Compare at a Glance
- Needlestick transmission risk: HBV 6–30%, HIV 0.3%, HCV 0.2%
- Survival outside the body: HBV at least 7 days on surfaces; HIV dies quickly
- Vaccine available: HBV yes (over 90% effective); HCV and HIV no
- Curable: HCV yes with antiviral treatment; HBV and HIV are treatable but not typically cured
Other Viruses That Spread Through Blood
Beyond the big three, a number of other viruses have a bloodborne phase, meaning the virus circulates in the bloodstream and can potentially be transmitted through blood transfusions, shared needles, or other blood-to-blood contact. These don’t get the same regulatory attention because they’re either less common, less severe, or primarily spread through other routes like mosquito bites. But they matter, especially for blood supply safety.
West Nile virus is one of the best-documented examples. After arriving in the United States in 1999, it caused at least 23 confirmed transfusion-transmitted infections in 2002. At peak transmission times in affected areas, the risk was estimated as high as one infected unit per thousand blood donations. This prompted blood banks to implement routine genetic screening for the virus starting in 2003. West Nile is primarily a mosquito-borne illness, but its ability to contaminate the blood supply made it a bloodborne concern as well.
Dengue virus similarly circulates in the bloodstream during infection and has been detected in blood donations from countries like Brazil and Honduras. Confirmed transfusion-transmitted cases remain extremely rare, with only a single documented case from Hong Kong, but dengue’s presence in donor blood keeps it on the watchlist.
Several other viruses round out the broader category. Parvovirus B19 (the virus that causes “fifth disease” in children) can be transmitted through blood products. Human herpesvirus 8, linked to Kaposi’s sarcoma, has a phase where it circulates in the blood, though transfusion transmission hasn’t been definitively proven. Ebola and other hemorrhagic fever viruses are highly present in blood during active illness. Even certain strains of influenza have a viremic phase where the virus enters the bloodstream, though blood-to-blood transmission hasn’t been confirmed for flu.
Why the Distinction Matters
The practical difference between a “primary” bloodborne pathogen like HBV and a virus that merely has a bloodborne phase comes down to how commonly and efficiently the virus spreads through blood in real-world conditions. Hepatitis B, hepatitis C, and HIV are the viruses most likely to be transmitted through occupational needlesticks, shared injection equipment, or contaminated medical tools. They’re the reason healthcare workers follow universal precautions, treating all blood as potentially infectious regardless of a patient’s known status.
The broader list of blood-transmissible viruses matters most for blood banking and transfusion medicine. Screening donated blood for these additional pathogens protects recipients who may be immunocompromised or receiving large volumes of blood products. Each time a new virus demonstrates the ability to survive in stored blood and infect a recipient, screening protocols evolve to match.
For anyone working in healthcare, emergency response, tattooing, or other fields involving potential blood exposure, the core precautions remain the same: barriers like gloves, proper disposal of sharps, hepatitis B vaccination, and prompt reporting of any exposure incident. These measures protect against the full spectrum of bloodborne viruses, not just the ones you can name.